The mortality rate for bladder malignant neoplasms in Brazil among women demonstrates a stable to slight upward trend from 2024 to 2028. The projected increase from 1.5 deaths per 100,000 women in 2024 to 1.7 by 2028 indicates a year-over-year rise primarily occurring after 2026. Comparatively, since 2023 figures are not available but assuming continuity, the Compound Annual Growth Rate (CAGR) over these five years can be inferred as modest.
Future trends to watch include potential healthcare advancements impacting survival rates, government policies enhancing early detection, and shifts in risk factors like smoking prevalence affecting bladder cancer incidences among women in Brazil.
